SCHEMBL28840985

SCHEMBL28840985

O=C(CC1CNCCO1)OC(=O)N1CCNCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37
CHRNB3 Q05901 1/20 0.37
CHRNA6 Q15825 1/20 0.37
CA2 P00918 2/20 0.34
CHKA P35790 1/20 0.34
WNT1 P04628 1/20 0.33
GSK3B P49841 1/20 0.33
DYRK1A Q13627 1/20 0.33
SLC6A2 P23975 7/20 0.32
SLC6A3 Q01959 6/20 0.32
SLC6A4 P31645 4/20 0.32
ADRB2 P07550 1/20 0.32
HTR1A P08908 1/20 0.32
HTR2A P28223 1/20 0.32
ADRA1A P35348 1/20 0.32
HTR2B P41595 1/20 0.32
ADRA2C P18825 1/20 0.32
CA12 O43570 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28840987 0.78 CYP1A2 (0.41) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL17560336 0.75 CHRNB2 (0.47) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL1655323 0.75 ADRA2C (0.42) WNT1GSK3BDYRK1ASLC6A2SLC6A3
Hydrochloric Acid SCHEMBL15550523 0.74 ADRA2C (0.41) WNT1GSK3BDYRK1ASLC6A2SLC6A3
SCHEMBL30275082 0.73 SLC6A2 (0.43) SLC6A2SLC6A3SLC6A4ADRB2HTR1A
SCHEMBL2921129 0.73 SLC6A2 (0.43) SLC6A2SLC6A3SLC6A4ADRB2HTR1A
SCHEMBL27609653 0.73 SLC6A2 (0.38) WNT1GSK3BDYRK1ASLC6A2SLC6A3
SCHEMBL2444480 0.73 ALDH1A1 (0.43) CA2CHKAWNT1GSK3BDYRK1A
SCHEMBL28213419 0.72 CHRNB2 (0.45) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL28019673 0.72 SSTR4 (0.39) WNT1GSK3BDYRK1ASLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106397418-A APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBVIE公司 2017-02-15 CN disclosed